Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells

Paul J. Collins, Christopher P. Fox, Lindsay George, Hayden Pearce, Gordon Ryan, Carmela De Santo, Francis Mussai, David Lewis, Heather Long, Claire Shannon-Lowe

Blood (2021) 137 (2): 203–215.

https://doi.org/10.1182/blood.2020005611

Published: 2021

Includes: Supplemental data

Journal Articles

Characterization of INCB00928, a Potent and Selective ALK2 Inhibitor for the Treatment of Anemia

Yaoyu Chen, Matthew C. Stubbs, PhD, Michelle Pusey, Xiaoming Wen, Robert J. Collins, Kanishk Kapilashrami, Mark Rupar, Pramod Thekkat, Luping Lin, PhD, Kevin Bowman, Yan-ou Yang, Sharon Diamond, Swamy Yeleswaram, PhD, Sunkyu Kim, Holly K. Koblish, PhD, Yingnan Chen, Susan Wee, PhD BS

Blood (2020) 136 (Supplement 1): 52.

https://doi.org/10.1182/blood-2020-136138

Published: 2020

Journal Articles

Identification of Leukemia Associated Minor Histocompatibility Antigens through Computational Prediction and Targeted Mass Spectrometry

Jefferson L. Lansford, BS, Udara Dharmasiri, PhD, Shengjie Chai, BS, Sally A. Hunsucker, PhD, Dante S. Bortone, PhD, James E. Keating, BS, Ian M. Schlup, Gary L. Glish, PhD, Edward J. Collins, PhD, Gheath Alatrash, DO, PhD, Jeffrey J. Molldrem, MD, Paul M. Armistead, MD PhD, Benjamin G. Vincent, MD

Blood (2017) 130 (Supplement 1): 207.

https://doi.org/10.1182/blood.V130.Suppl_1.207.207

Published: 2017

Journal Articles

The Pan-PIM Inhibitor INCB053914 Displays Potent Synergy at Low Doses in Combination with Ruxolitinib in Pre-Clinical Models of MPNs

Lucia Mazzacurati, Que T. Lambert, Robert J. Collins, Holly K. Koblish, PhD, Bruce Ruggeri, Matthew C. Stubbs, Gary W. Reuther, PhD

Blood (2017) 130 (Supplement 1): 1661.

https://doi.org/10.1182/blood.V130.Suppl_1.1661.1661

Published: 2017

Journal Articles

Timing of Primary Prophylaxis G-CSF Use during Chemotherapy in Elderly Patients with NHL

Shuling Li, PhD, Iberia Romina Sosa, MD PhD, Julia T Molony, MS, John H Page, MD ScD, Richard L Barron, MS, Jiannong Liu, PhD, Phuong Khanh Morrow, MD, Scott Stryker, MD DrPH, John F Acquavella, PhD, Allan J Collins, MD FACP

Blood (2014) 124 (21): 6013.

https://doi.org/10.1182/blood.V124.21.6013.6013

Published: 2014

Journal Articles

Oral Antimicrobial Drug Use during Chemotherapy in Medicare Enrollees with NHL

Julia T Molony, MS, Iberia Romina Sosa, MD PhD, Shuling Li, PhD, John H Page, MD ScD, Richard L Barron, MS, Jiannong Liu, PhD, Phuong Khanh Morrow, MD, Scott Stryker, MD DrPH, John F Acquavella, PhD, Allan J Collins, MD FACP

Blood (2014) 124 (21): 6022.

https://doi.org/10.1182/blood.V124.21.6022.6022

Published: 2014

Journal Articles

UNC-GRK4-1: An Allele Specific Cancer Testis Antigen Identified Through Genomic Screening

Udara Dharamsiri, PhD, Sally A. Hunsucker, PhD, Benjamin G. Vincent, MD, Michael Wu, PhD, Edward J. Collins, PhD, Shoudan Liang, PhD, Jeffrey J. Molldrem, MD, Paul M. Armistead, MD, PhD

Blood (2013) 122 (21): 3246.

https://doi.org/10.1182/blood.V122.21.3246.3246

Published: 2013

Journal Articles

All- Trans -Retinoic Acid (ATRA) Causes Extensive Differentiation In the NPM Mutant, Non-APL Leukemic Cell Line OCI-AML3

Matthew A. Kutny, MD, Steven J. Collins, MD, Keith Loeb, MD, PhD, Roland B. Walter, MD, PhD, Soheil Meshinchi, MD, PhD

Blood (2010) 116 (21): 3305.

https://doi.org/10.1182/blood.V116.21.3305.3305

Published: 2010

Journal Articles

A Systems Biology Approach to Study the Acquisition of Adult Repopulating Potential During Hematopoietic Stem Cell Ontogeny.

Shannon McKinney-Freeman, PhD, Hu Li, PhD, Matthew Curran, Sabine Loewer, PhD, Catherine Spina, Olaia Naveiras, MD, James J. Collins, PhD, George Q. Daley, MD, PhD

Blood (2009) 114 (22): 1479.

https://doi.org/10.1182/blood.V114.22.1479.1479

Published: 2009

Journal Articles

Selective deletion of antigen-specific CD8 + T cells by MHC class I tetramers coupled to the type I ribosome-inactivating protein saporin

Paul R. Hess, Carie Barnes, Matthew D. Woolard, Michael D. L. Johnson, John M. Cullen, Edward J. Collins, Jeffrey A. Frelinger

Blood (2006) 109 (8): 3300–3307.

https://doi.org/10.1182/blood-2006-06-028001

Published: 2006

Journal Articles

MEK blockade converts AML differentiating response to retinoids into extensive apoptosis

Michele Milella, Marina Konopleva, Cristina M. Precupanu, Yoko Tabe, Maria Rosaria Ricciardi, Chiara Gregorj, Steven J. Collins, Bing Z. Carter, Carmen D'Angelo, Maria Teresa Petrucci, Robin Foà, Francesco Cognetti, Agostino Tafuri, Michael Andreeff

Blood (2006) 109 (5): 2121–2129.

https://doi.org/10.1182/blood-2006-05-024679

Published: 2006

Journal Articles

IL-3–induced enhancement of retinoic acid receptor activity is mediated through Stat5, which physically associates with retinoic acid receptors in an IL-3–dependent manner

Jutong Si, Steven J. Collins

Blood (2002) 100 (13): 4401–4409.

https://doi.org/10.1182/blood-2001-12-0374

Published: 2002

Journal Articles

Acute promyelocytic leukemia: STATs, HATs, and HDACs

Steven J. Collins

Blood (2002) 99 (8): 2635.

https://doi.org/10.1182/blood.V99.8.2635

Published: 2002

Journal Articles

The cytokines IL-3 and GM-CSF regulate the transcriptional activity of retinoic acid receptors in different in vitro models of myeloid differentiation

Barton S. Johnson, LeMoyne Mueller, Jutong Si, Steven J. Collins

Blood (2002) 99 (3): 746–753.

https://doi.org/10.1182/blood.V99.3.746

Published: 2002

Journal Articles

Multipotent hematopoietic cell lines derived from C/EBPα(−/−) knockout mice display granulocyte macrophage–colony-stimulating factor, granulocyte– colony-stimulating factor, and retinoic acid–induced granulocytic differentiation

Steven J. Collins, Jon Ulmer, Louise E. Purton, Gretchen Darlington

Blood (2001) 98 (8): 2382–2388.

https://doi.org/10.1182/blood.V98.8.2382

Published: 2001

Journal Articles

All-trans retinoic acid enhances the long-term repopulating activity of cultured hematopoietic stem cells

Louise E. Purton, Irwin D. Bernstein, Steven J. Collins

Blood (2000) 95 (2): 470–477.

https://doi.org/10.1182/blood.V95.2.470

Published: 2000

Journal Articles

All-Trans Retinoic Acid Delays the Differentiation of Primitive Hematopoietic Precursors (lin − c- kit + Sca-1 + ) While Enhancing the Terminal Maturation of Committed Granulocyte/Monocyte Progenitors

Louise E. Purton, Irwin D. Bernstein, Steven J. Collins

Blood (1999) 94 (2): 483–495.

https://doi.org/10.1182/blood.V94.2.483

Published: 1999

Journal Articles

D3: A Gene Induced During Myeloid Cell Differentiation of Lin lo c-Kit + Sca-1 + Progenitor Cells

Sarah R. Weiler, John M. Gooya, Mariaestela Ortiz, Schickwann Tsai, Steven J. Collins, Jonathan R. Keller

Blood (1999) 93 (2): 527–536.

https://doi.org/10.1182/blood.V93.2.527

Published: 1999

Journal Articles

Acute Promyelocytic Leukemia: Relieving Repression Induces Remission

Steven J. Collins

Blood (1998) 91 (8): 2631–2633.

https://doi.org/10.1182/blood.V91.8.2631.2631_2631_2633

Published: 1998

Journal Articles

Neonatal alloimmune thrombocytopenia due to a new platelet-specific alloantibody

JG McFarland, V Blanchette, J Collins, PJ Newman, R Wang, RH Aster

Blood (1993) 81 (12): 3318–3323.

https://doi.org/10.1182/blood.V81.12.3318.3318

Published: 1993

NARROW

Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells

Characterization of INCB00928, a Potent and Selective ALK2 Inhibitor for the Treatment of Anemia

Identification of Leukemia Associated Minor Histocompatibility Antigens through Computational Prediction and Targeted Mass Spectrometry

The Pan-PIM Inhibitor INCB053914 Displays Potent Synergy at Low Doses in Combination with Ruxolitinib in Pre-Clinical Models of MPNs

Timing of Primary Prophylaxis G-CSF Use during Chemotherapy in Elderly Patients with NHL

Oral Antimicrobial Drug Use during Chemotherapy in Medicare Enrollees with NHL

UNC-GRK4-1: An Allele Specific Cancer Testis Antigen Identified Through Genomic Screening

All- Trans -Retinoic Acid (ATRA) Causes Extensive Differentiation In the NPM Mutant, Non-APL Leukemic Cell Line OCI-AML3

A Systems Biology Approach to Study the Acquisition of Adult Repopulating Potential During Hematopoietic Stem Cell Ontogeny.

Selective deletion of antigen-specific CD8 + T cells by MHC class I tetramers coupled to the type I ribosome-inactivating protein saporin

MEK blockade converts AML differentiating response to retinoids into extensive apoptosis

IL-3–induced enhancement of retinoic acid receptor activity is mediated through Stat5, which physically associates with retinoic acid receptors in an IL-3–dependent manner

Acute promyelocytic leukemia: STATs, HATs, and HDACs

The cytokines IL-3 and GM-CSF regulate the transcriptional activity of retinoic acid receptors in different in vitro models of myeloid differentiation

Multipotent hematopoietic cell lines derived from C/EBPα(−/−) knockout mice display granulocyte macrophage–colony-stimulating factor, granulocyte– colony-stimulating factor, and retinoic acid–induced granulocytic differentiation

All-trans retinoic acid enhances the long-term repopulating activity of cultured hematopoietic stem cells

All-Trans Retinoic Acid Delays the Differentiation of Primitive Hematopoietic Precursors (lin − c- kit + Sca-1 + ) While Enhancing the Terminal Maturation of Committed Granulocyte/Monocyte Progenitors

D3: A Gene Induced During Myeloid Cell Differentiation of Lin lo c-Kit + Sca-1 + Progenitor Cells

Acute Promyelocytic Leukemia: Relieving Repression Induces Remission

Neonatal alloimmune thrombocytopenia due to a new platelet-specific alloantibody

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only